Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system

Stefanie Rauch, Francesco Costacurta, Helge Schöppe, Ju Yi Peng, David Bante, Ela Emilie Erisoez, Bernhard Sprenger, Xi He, Seyed Arad Moghadasi, Laura Krismer, Anna Sauerwein, Anne Heberle, Toni Rabensteiner, Dai Wang, Andreas Naschberger, Theresia Dunzendorfer-Matt, Teresa Kaserer, Dorothee von Laer, Emmanuel Heilmann*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry